Skip to main content
. 2014 Sep 5;25(11):2178–2184. doi: 10.1093/annonc/mdu445

Table 2.

Correlation of PD-L1 expression and clinico-pathological factors in non-ccRCC

Characteristic % Positive tumor cell membrane
P value TIMC
P value
<5% (negative) (N = 90, 89.1%), n (%) 5% or more (positive) (N = 11, 10.9%), n (%) Total (N = 101) Score = 0 (negative) (N = 44, 43.6%), n (%) Score >0 (positive) (N = 57, 56.4%), n (%) Total (N = 101)
Stage
 1 52 (58) 2 (20) 54 (53) 0.01 24 (55) 30 (54) 54 (53) 0.35
 2 18 (20) 1 (10) 19 (19) 11 (25) 8 (14) 19 (19)
 3 14 (16) 4 (40) 18 (18) 7 (16) 11 (20) 18 (18)
 4 6 (7) 3 (30) 9 (9) 2 (5) 7 (12) 9 (9)
 Unknown 0 1 (1) 1 (1) 0 1 (1) 1 (1)
Fuhrman grade
 I/II 51 (57) 2 (18) 53 (52.4) 0.03 23 (53) 30 (53) 53 (52.4) 0.11
 III 31 (35) 7 (64) 38 (37.6) 19 (44) 19 (33) 38 (37.6)
 IV 7 (8) 2 (18) 9 (9) 1 (1) 8 (14) 9 (9)
 Unknown 1 (1) 0 1 (1) 1 (1) 0 1 (1)
Histology
 Chromophobe 34 (94.4) 2 (5.6) 36 (36) 0.1 23 (63.9) 13 (36.1) 36 (36) 0.001
 Collecting duct 4 (80) 1 (20) 5 (5) 0 (0) 5 (100) 5 (5)
 Papillary 45 (90) 5 (10) 50 (49) 20 (40) 30 (60) 50 (49)
 Translocation 7 (70) 3 (30) 10 (10) 1 (10) 9 (90) 10 (10)

TIMC, tumor-infiltrating mononuclear cells.